ABBOTINDIA vs AHCL: Stock Comparison
ABBOTT INDIA is the larger company by market capitalisation. ABBOTT INDIA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ABBOTINDIA leads 10; AHCL leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| Live Price | ₹26,345 | ₹27 |
| Day Change | -0.98% | -3.54% |
| Volume | 16,959 | 44.68 L |
| 52-Week High | ₹30,655 | ₹161 |
| 52-Week Low | ₹24,650 | ₹12.91 |
| Distance from 52W High | -14.06% | -83.23% |
Valuation
| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| Market Cap | ₹55,889 Cr | ₹1,435 Cr |
| P/E Ratio | 33.81x | 45x |
| P/B Ratio | 13.09x | 5.58x |
| EPS | ₹201.66 | ₹0.25 |
| Book Value | ₹2,246.75 | ₹4.79 |
| Dividend Yield | 0.5% | 0% |
Growth
| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| Revenue Growth (TTM YoY) | 6.5% | 4% |
| EPS Growth (TTM YoY) | 7.6% | -54.8% |
| Qtr Sales Growth | 6.09% | 20.61% |
| Qtr Profit Growth | 8.51% | 107.43% |
Profitability & Leverage
| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| ROE | 36.66% | 11.42% |
| ROCE | 42.6% | 10.76% |
| Net Margin | 22.4% | 22.18% |
| Operating Margin | 30.37% | 26.89% |
| Debt to Equity | 0x | 0.17x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ABBOTINDIA | AHCL |
|---|---|---|
| Promoter Holding | 74.99% | 52.68% |
| FII Holding | 0.38%▲ 0.12 pp | 1%▼ 0.67 pp |
| DII Holding | 8.78%▼ 0.15 pp | 0.3%▼ 0.92 pp |
| Public Holding | 15.85%▲ 0.04 pp | 46.02%▲ 1.59 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ABBOTT INDIA and ANLON HEALTHCARE.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.